KDAC THERAPEUTICS, INC.

Follow

Organization

CAMBRIDGE, MA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Combination of a selective histone deacetylase 3 (HDAC3) inhibitor...
- Patent number 12,128,018
- Issue date Oct 29, 2024
- KDAc Therapeutics, Inc.
- Edward Holson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION OF A SELECTIVE HISTONE DEACETYLASE 3 (HDAC3) INHIBITOR...
- Publication number 20210177781
- Publication date Jun 17, 2021
- KDAc Therapeutics, Inc.
- Edward Holson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF A SELECTIVE HISTONE DEACETYLASE 3 (HDAC3) INHIBITOR...
- Publication number 20190216754
- Publication date Jul 18, 2019
- KDAc Therapeutics, Inc.
- Edward Holson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

NIH Research Projectlast 12 months

processing...

Count: 2

Research Projects

Information Research Project
Selective HDAC3 Inhibitors as a Novel Therapy for Drug Addiction
- Application id 9140978
- Award notice date May 11, 2016
Information Research Project
Small Molecule Selective HDAC3 Inhibitors as a Novel Therapy for PTSD
- Application id 9141690
- Award notice date Mar 21, 2016